ACET · Adicet Bio, Inc. · Proposed Sales
Market Cap
$89.12M
Shares
9.36M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-04-09 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 78,499 | 2026-04-09 | Themis Trading LLC |
| 2026-04-08 | OrbiMed Israel Partners II, L.P. | Shareholder | 40,416 | 2026-04-08 | Themis Trading LLC |
| 2026-04-07 | OrbiMed Israel Partners Limited Partnership | Shareholder | 64,242 | 2026-04-07 | Themis Trading LLC |
| 2024-06-05 | Kauffman Michael | Director | 5,900 | 2024-06-05 | Morgan Stanley Smith Barney LLC Executive Services |
| 2023-09-29 | CHEN SCHOR | Officer, Director | 5,500 | 2023-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings
Key facts
CIK
1720580
CUSIP
007002207
13F (30d)
22 filings
22 filers
Visit website
Investor relations